FDA 483 - Transpire Bio Inc. - November 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Transpire Bio, Inc. in Weston, FL, a biopharmaceutical analytical facility, was cited for three observations during an FDA inspection. The firm's study reports did not accurately disclose all study activities, including erroneous data reporting and omitted protocols. Additionally, a full method validation was not completed prior to conducting sample analysis for an in vitro bioequivalence study, and the firm failed to retain reserve samples from all shipments of reference standards.
ID · ab087473-b487-49fb-9037-86b5cbd5dd17